New way to kill cancer found using body's immune system

July 21, 2009

( -- Scientists have discovered a new way of killing cancer cells in a breakthrough that could eventually lead to new treatments for a range of different cancers.

Researchers at The University of Manchester, working with colleagues at the University of Southampton, investigated how antibody treatments make cancer cells kill themselves and found a previously undiscovered mechanism that could, in future, be even more effective in causing their death.

When antibodies bind to cells, including cancer cells, they can ‘flag’ those targets for destruction by the body’s but this latest study has shown that antibodies can kill cancer cells directly. When the antibody binds, it causes lysosomes - small acid-containing sacs - inside the cell to swell and burst, rapidly releasing their toxic contents with fatal results for the cancer cell.

The study, published in the , offers hope of more alternative approaches to killing cancer cells that may have become resistant to the traditional chemotherapy treatments.

”A number of antibody treatments for cancer have been developed over the last decade and some of them are a huge step forward in treatment,” said Professor Tim Illidge, in Manchester’s School of Cancer and Imaging Sciences at the Paterson Institute for Cancer Research.

“Our research focused on several antibodies that bind to a molecule found on many leukaemia and called CD20. Until now scientists did not understand exactly how these antibodies work as treatments for these blood cancers but our research not only identifies how they kill the cancer cells but also provides exciting insights into how other antibodies that use this mechanism might be developed.”

Dr Mark Cragg, from the University of Southampton, added: “Our findings are significant and open up the possibility of applying the knowledge of how antibodies can be developed to trigger and may enable us to design treatments for other cancers.”

The large study was funded by the Association for International Cancer Research (AICR), Leukaemia Research, Cancer Research UK and Tenovus. Dr Mark Matfield of AICR, said: “The discovery of a new mechanism by which cancer cells kill themselves is an important step forward in cancer research. Killing the cancer cells is the basis of all successful cancer treatments.”

Dr David Grant, of Research, said: "The discovery of the unique pathway used by antibody therapies to kill cancer cells has, for the first time, revealed why they are more effective than chemotherapy. This may lead to new treatments for patients with blood cancers who cannot be cured using conventional chemotherapy.”

Dr Lesley Walker, Cancer Research UK’s Director of Cancer Information, said: “Although it’s at an early stage, this research provides valuable clues as to how monoclonal antibodies kill , and could lead to more effective treatments for cancer in the future.”

Dr Ian Lewis, Research Manager of Tenovus, added: “The beauty of this research is that it shows how the body’s own immune system can be mobilised to selectively destroy a patient’s own cancer. Normally the immune system struggles to tell the difference between a cancer cell and a healthy cell, but thanks to this research we now know how successful antibody treatments work and therefore how to apply it to the whole area of antibody therapy for cancer.”

Provided by University of Manchester (news : web)

Related Stories

Recommended for you

Soy, cruciferous vegetables associated with fewer common breast cancer treatment side effects

December 11, 2017
Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects ...

CAR T, immunotherapy bring new hope for multiple myeloma patients

December 11, 2017
Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other ...

Tracking how multiple myeloma evolves by sequencing DNA in the blood

December 10, 2017
Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, ...

Landmark CAR-T cancer study published

December 10, 2017
Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

Study finds emojis promising tool for tracking cancer patients' quality of life

December 10, 2017
In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients' physical, emotional and overall quality ...

Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant

December 10, 2017
Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial ...


Adjust slider to filter visible comments by rank

Display comments: newest first

3 / 5 (6) Jul 21, 2009
Fantastic! As a cancer survivor and facing the possibility of a recurrence, I'm heartened to see developments like this. Chemo/radiation is quite destructive to good cells (I personally lost about 24% of my body mass during treatment) and we need better solutions.
1 / 5 (1) Jul 21, 2009
glad to hear you survived forfreeminds. my 4 old has leukemia (ALL), and is almost finished with his 3 yr chemo stint, so i too hope something comes of this. Luckily he was on a research plan from St. Judes that enabled him to avoid any direct radiation. :)
1 / 5 (1) Jul 22, 2009
Long, cool, daily baths in electrically grounded water may help. I am only three years into my research, but these are indications so far!
not rated yet Jul 22, 2009
the baths help with treatment or preventative?
not rated yet Jul 22, 2009
Use Artemisinin to kill the cancer, then immunotherapy to prevent recurrence.
Chemo IS the cancer of our times, The big moneyspinner for big pharma!
Mediaevil medicine long past it's use by date.
1 / 5 (1) Jul 24, 2009
flxer-how you you propose to go about doing that in the blood stream and in the bone marrow as with leukemia, where your marrow is actually creating mutated cells (leukemia)? i might agree with you for a tumor based cancer, but for something like leukemia, i dont see how that could possibly be feasible.
And the biggest cancer of chemo is its cost....I had my employer screw up my insurance for about a month in a half once, and got a total of $114,000 in bills for that timeframe (which the insurance backpaid of course, but not before a bunch went to collections)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.